According to Ness, the success of HeartFlow’s IPO reflects the market validation of the overall rationale for using AI in ...

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

It seems there’s fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, ...

Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

This year's cohort of new issues are rallying on their first day of trading, which bodes well for IPOs to come.

Seven IPOs and two SPACs debuted this week, while five small IPOs and seven SPACs submitted initial filings. Read more here.